Inhibition of the cyclooxygenase/lipoxygenase pathways to improve interferon alfa efficacy in chronic hepatitis C: a wrong track

Hepatology. 2000 Feb;31(2):547-8. doi: 10.1002/hep.510310248.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Drug Synergism
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon-alpha / therapeutic use*
  • Lipoxygenase Inhibitors / therapeutic use*

Substances

  • Antiviral Agents
  • Cyclooxygenase Inhibitors
  • Interferon-alpha
  • Lipoxygenase Inhibitors